Status:
COMPLETED
Safety and Efficacy of Concurrent MACE and Mitrofanoff Procedures
Lead Sponsor:
Mohammad Daboos
Conditions:
Fecal Incontinence
Urinary Incontinence
Eligibility:
All Genders
5-14 years
Phase:
NA
Brief Summary
This was a prospective study. The study period was from January 2022 to July 2025. The study included 30 patients suffering from combined fecal and urinary incontinence submitted for concurrent Malone...
Detailed Description
-This was a prospective study, at Al-Azhar university hospitals. The study period was from January 2022 to July 2025. The study included all patients suffering from combined fecal and urinary incontin...
Eligibility Criteria
Inclusion
- all patients suffering from combined fecal and urinary incontinence due to neuropathic etiology
- failure of all trials of non-surgical managements
Exclusion
- The patients responding to medical treatments,
- patients with previous appendectomy,
- patients with marked reduction of bladder capacity,
- patients with Brain affection (Cerebral palsy, etc..)
- and patients with isolated fecal or urinary incontinence
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 22 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07206719
Start Date
January 1 2022
End Date
September 22 2025
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohammad Daboos
Cairo, Egypt, 115678